Briacell TherapeuticsBCTXLPreferred / convertible
13F holders, Q1 2026 (March 31)15holders
1famous investor
$1.03avg. 13F price*
At the end of Q1 2026, 15 institutions reported holding Briacell Therapeutics Corp. (BCTXL) in their 13F filings. The largest holders were Citadel Advisors ($1.0M), Armistice Capital, LLC ($553K) and Sabby Management, LLC ($392K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Briacell Therapeutics Corp.
- CUSIP
- 107930125
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 15 | $3.7M |
| Exits | 0 | $0 |
Ownership 15 holders
| Citadel Advisors | — | New | 1,048,759 | $1.0M |
| Armistice Capital, LLC | — | New | 536,600 | $553K |
| Sabby Management, LLC | — | New | 380,686 | $392K |
| Cable Car Capital, LP | — | New | 321,898 | $332K |
| Empery Asset Management, LP | — | New | 300,000 | $309K |
| Heights Capital Management, Inc. | — | New | 300,000 | $300K |
| MYDA Advisors LLC | — | New | 200,000 | $206K |
| Hudson Bay Capital Management LP | — | New | 125,402 | $125K |
| Warberg Asset Management LLC | — | New | 115,000 | $118K |
| Clear Street Group Inc. | — | New | 104,196 | $107K |
| Boothbay Fund Management, LLC | — | New | 20,000 | $84K |
| Iridian Asset Management LLC | — | New | 65,000 | $67K |
| LuminArx Capital Management LP | — | New | 25,000 | $26K |
| Susquehanna International Group, LLP | — | New | 23,889 | $24K |
| FNY Investment Advisers, LLC | — | New | 7,500 | $7K |
"% of holder's portfolio" is BCTXL's weight in each manager's 13F, not the share of Briacell Therapeutics Corp. the manager owns.